Your browser is no longer supported. Please, upgrade your browser.
PSTX [NASD]
Poseida Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.62 Insider Own16.80% Shs Outstand62.30M Perf Week-3.69%
Market Cap301.32M Forward P/E- EPS next Y-2.59 Insider Trans2.58% Shs Float37.30M Perf Month-33.33%
Income-162.60M PEG- EPS next Q-0.35 Inst Own46.70% Short Float1.75% Perf Quarter-27.58%
Sales- P/S- EPS this Y-49.90% Inst Trans0.03% Short Ratio4.02 Perf Half Y-45.16%
Book/sh2.41 P/B1.95 EPS next Y-6.40% ROA-51.40% Target Price27.67 Perf Year-45.03%
Cash/sh3.09 P/C1.52 EPS next 5Y2.70% ROE-78.70% 52W Range4.51 - 13.64 Perf YTD-30.98%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-66.13% Beta-
Dividend %- Quick Ratio6.40 Sales past 5Y- Gross Margin- 52W Low2.44% ATR0.42
Employees254 Current Ratio6.40 Sales Q/Q- Oper. Margin- RSI (14)23.57 Volatility7.49% 7.14%
OptionableYes Debt/Eq0.00 EPS Q/Q-8.80% Profit Margin- Rel Volume0.68 Prev Close4.70
ShortableYes LT Debt/Eq0.20 EarningsNov 09 AMC Payout- Avg Volume162.62K Price4.62
Recom1.20 SMA20-20.87% SMA50-29.35% SMA200-41.21% Volume50,800 Change-1.70%
Jan-07-22Initiated Cantor Fitzgerald Overweight $24
May-18-21Initiated BTIG Research Buy $40
Aug-04-20Initiated William Blair Outperform
Aug-04-20Initiated Piper Sandler Overweight $30
Aug-04-20Initiated BofA Securities Buy $20
Jan-10-22 08:00AM  
Jan-05-22 10:17AM  
09:37AM  
Dec-20-21 08:00AM  
Dec-14-21 12:00PM  
Dec-13-21 08:00AM  
Nov-24-21 10:00AM  
Nov-19-21 08:50AM  
Nov-11-21 11:54AM  
Nov-09-21 04:05PM  
08:05AM  
Nov-08-21 10:46AM  
Nov-03-21 08:00AM  
Oct-13-21 08:00AM  
Oct-12-21 07:31AM  
07:00AM  
Oct-06-21 11:45AM  
Oct-01-21 08:05AM  
Sep-16-21 11:31AM  
Sep-07-21 08:00AM  
Sep-02-21 12:48PM  
Aug-31-21 03:32PM  
10:00AM  
Aug-30-21 08:00AM  
Aug-12-21 04:05PM  
Jul-26-21 08:00AM  
Jun-02-21 08:00AM  
May-11-21 04:05PM  
08:00AM  
May-06-21 08:00AM  
May-05-21 08:00AM  
Apr-28-21 05:33AM  
Apr-27-21 05:00PM  
Apr-08-21 09:00AM  
Mar-23-21 08:00AM  
Mar-11-21 04:05PM  
Feb-24-21 12:22PM  
09:00AM  
Feb-10-21 08:00AM  
Jan-28-21 03:27AM  
Jan-04-21 08:00AM  
Dec-18-20 08:00AM  
Dec-17-20 08:00AM  
Dec-11-20 09:09PM  
Dec-05-20 01:45PM  
Nov-12-20 04:05PM  
Nov-02-20 08:00AM  
Oct-21-20 08:00AM  
Oct-12-20 01:50PM  
Sep-23-20 07:00AM  
Sep-18-20 08:00AM  
Sep-16-20 09:30AM  
Sep-04-20 11:15AM  
Sep-03-20 09:00AM  
Sep-02-20 01:00PM  
Sep-01-20 11:00PM  
04:09PM  
12:40PM  
11:00AM  
Aug-31-20 09:16AM  
Aug-29-20 07:54PM  
Aug-28-20 04:49PM  
Aug-25-20 10:30PM  
Aug-24-20 05:31PM  
Aug-20-20 05:28PM  
04:05PM  
01:13PM  
Aug-19-20 05:47PM  
03:30PM  
Aug-18-20 02:09AM  
Aug-17-20 04:55PM  
Jul-16-20 09:00AM  
Jul-10-20 11:23AM  
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company is developing P-BCMA-101, an autologous chimeric antigen receptor T cell (CAR-T) targeting B cell maturation antigen that is in Phase II clinical trial; P-PSMA-101, an autologous CAR-T product candidate for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC) is in Phase I clinical trials; P-BCMA-ALLO1, an allogeneic CAR-T product candidate to treat relapsed/refractory multiple myeloma patients; P-MUC1C-ALLO1, an allogeneic CAR-T product candidate for multiple solid tumor indications; and P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. It is also developing P-OTC-101, a liver-directed gene therapy for the treatment of ornithine transcarbamylase; and P-MMUT-101, a liver-directed gene therapy for the treatment of methylmalonic acidemia. In addition, the company is developing a portfolio of allogeneic dual CAR product candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mylet JohannaChief Financial OfficerDec 21Option Exercise1.595,7169,06134,231Dec 22 04:53 PM
Spear Matthew A.Chief Medical OfficerDec 06Option Exercise1.3210,00013,22061,485Dec 08 08:38 PM
Malin Life Sciences Holdings LCommon director with IssuerDec 06Buy6.901,82812,6139,685,673Dec 07 06:03 AM
Malin Life Sciences Holdings LCommon director with IssuerDec 02Buy6.884,29629,5509,683,845Dec 02 06:33 PM
Malin Life Sciences Holdings LCommon director with IssuerDec 01Buy6.8518,365125,8069,679,549Dec 02 06:33 PM
Malin Life Sciences Holdings LCommon director with IssuerNov 30Buy6.8528,592195,8389,661,184Dec 02 06:33 PM
Malin Life Sciences Holdings LCommon director with IssuerNov 29Buy6.8911,05776,2099,632,592Nov 29 07:55 PM
Malin Life Sciences Holdings LCommon director with IssuerNov 26Buy6.8127,251185,4929,621,535Nov 29 07:55 PM
Malin Life Sciences Holdings LCommon director with IssuerNov 24Buy6.891,0547,2609,594,284Nov 29 07:55 PM
Malin Life Sciences Holdings LCommon director with IssuerNov 23Buy6.7714,62598,9899,593,230Nov 23 06:41 PM
Ostertag EricChief Executive OfficerNov 19Option Exercise9.151,0009,150697,422Nov 22 07:50 PM
Malin Life Sciences Holdings LCommon director with IssuerNov 19Buy7.4411,10482,6509,578,605Nov 23 06:41 PM
Malin Life Sciences Holdings LCommon director with IssuerNov 18Buy7.1871,312511,6859,567,501Nov 18 08:24 PM
Ingalls Kerry D.Chief Operating OfficerNov 17Buy7.002,00014,0002,000Nov 18 09:12 PM
Malin Life Sciences Holdings LCommon director with IssuerNov 17Buy7.21280,3842,021,8219,496,189Nov 18 08:24 PM
Malin Life Sciences Holdings LCommon director with IssuerNov 16Buy7.1727,680198,3839,215,805Nov 18 08:24 PM
Ostertag EricChief Executive OfficerNov 08Sale7.0918,924134,1713,358,455Nov 10 06:06 PM
Ostertag EricChief Executive OfficerOct 11Option Exercise9.1518,525169,504696,422Oct 13 06:59 PM
Ostertag EricChief Executive OfficerOct 01Sale7.0220,029140,6043,367,506Oct 05 06:16 PM
Ostertag EricChief Executive OfficerSep 20Sale8.0020,000160,020160,696Sep 22 05:51 PM
Ostertag EricChief Executive OfficerSep 14Sale8.1420,000162,712180,696Sep 15 06:58 PM
Ostertag EricChief Executive OfficerSep 13Option Exercise8.1221,281172,729675,415Sep 15 06:58 PM
Spear Matthew A.Chief Medical OfficerSep 09Option Exercise1.3210,00013,22051,485Sep 10 04:19 PM
Ostertag EricChief Executive OfficerSep 02Sale8.3461,262510,9253,377,085Sep 03 04:54 PM
Ostertag EricChief Executive OfficerSep 01Sale8.4651,149432,7213,406,384Sep 03 04:54 PM
Spear Matthew A.Chief Medical OfficerAug 20Option Exercise1.324,0005,28845,485Aug 24 05:12 PM
Spear Matthew A.Chief Medical OfficerAug 20Sale8.794,00035,14241,485Aug 24 05:12 PM
Ostertag EricChief Executive OfficerAug 06Option Exercise9.15111,1491,017,013654,134Aug 10 06:56 PM
Ostertag EricChief Executive OfficerAug 03Sale7.9919,936159,2893,430,847Aug 04 04:57 PM
Ostertag EricChief Executive OfficerAug 02Sale8.1313,737111,6823,440,382Aug 04 04:57 PM
Spear Matthew A.Chief Medical OfficerJul 28Option Exercise1.3220,00026,44041,485Jul 30 04:29 PM
Ostertag EricChief Executive OfficerJul 02Sale8.9127,542245,2743,446,952Jul 06 05:35 PM
Ostertag EricChief Executive OfficerJul 01Sale9.7720,563200,9013,460,124Jul 06 05:35 PM
Spear Matthew A.Chief Medical OfficerJun 17Option Exercise1.325,0006,61021,485Jun 21 08:02 PM
Spear Matthew A.Chief Medical OfficerJun 11Option Exercise1.324,0005,28820,485Jun 14 06:18 PM
Spear Matthew A.Chief Medical OfficerJun 11Sale9.444,00037,74716,485Jun 14 06:18 PM
Ostertag EricChief Executive OfficerJun 02Sale8.3440,722339,6213,469,958Jun 03 07:21 PM
Ostertag EricChief Executive OfficerJun 01Sale8.6141,194354,6803,489,434Jun 03 07:21 PM
Ostertag EricChief Executive OfficerMay 04Sale8.4435,986303,7223,509,135May 05 07:29 PM
Ostertag EricChief Executive OfficerMay 03Sale9.0118,326165,1173,526,346May 05 07:29 PM
Spear Matthew A.Chief Medical OfficerApr 23Option Exercise1.325,0006,61016,485Apr 23 08:49 PM
Spear Matthew A.Chief Medical OfficerApr 21Option Exercise1.324,0005,28815,485Apr 23 08:49 PM
Spear Matthew A.Chief Medical OfficerApr 21Sale8.444,00033,75211,485Apr 23 08:49 PM
Ostertag EricChief Executive OfficerApr 05Sale9.6657,819558,6683,532,624Apr 05 07:50 PM
Ostertag EricChief Executive OfficerApr 01Sale9.5557,181546,3303,560,277Apr 05 07:50 PM
Ostertag EricChief Executive OfficerMar 02Sale11.5457,060658,4153,590,111Mar 03 07:38 PM
Ostertag EricChief Executive OfficerMar 01Sale11.6757,940676,0463,617,401Mar 03 07:38 PM
Ostertag EricChief Executive OfficerFeb 23Option Exercise1.17111,395130,666542,985Feb 25 07:01 PM
Ostertag EricChief Executive OfficerFeb 16Sale10.00133,1491,332,036200,696Feb 17 05:28 PM
Ostertag EricChief Executive OfficerFeb 10Option Exercise1.2967,53487,119431,590Feb 12 05:03 PM
Ostertag EricChief Executive OfficerFeb 10Sale10.0012,389123,890333,845Feb 12 05:03 PM